This NIH grant continues support for the Type 1 Diabetes TrialNet Coordinating Center (TNCC). The TrialNet network identifies individuals with T1D at pre- and post-onset stages, enrolling them in trials for preventing disease progression and preserving insulin production. The TNCC manages ongoing and new studies, providing data/sample management (acquisition, QC, dissemination) and supporting diverse research. It oversees network administration, operations, and the evaluation, selection, and funding of Clinical Centers and central support units via subcontracts. The TNCC PD/PI contributes to network leadership. A Plan for Enhancing Diverse Perspectives (PEDP) is required for applications.
Opportunity ID: 353830
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DK-25-004 |
Funding Opportunity Title: | Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Food and Nutrition Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 26, 2024 |
Last Updated Date: | Apr 26, 2024 |
Original Closing Date for Applications: | Oct 17, 2024 |
Current Closing Date for Applications: | Oct 17, 2024 |
Archive Date: | Nov 22, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education State governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a wide range of research projects in varying stages of development, implementation and completion, and (2) provide data and sample management, including standardized acquisition, quality control, dissemination and public accessibility. The TNCC will be responsible for network administration and operations, including the evaluation, selection, and funding (through subcontracts) of Clinical Centers and central support units (such as laboratories) necessary for the conduct of TrialNets clinical studies. The TNCC PD/PI will be a voting member of the TrialNet Executive and Steering Committees, contributing to network leadership. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-004.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 353830 Full Announcement-RFA-DK-25-004 -> RFA-DK-25-004-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00286109 | Sep 16, 2024 | Oct 17, 2024 | View |
Package 1
Mandatory forms
353830 RR_SF424_5_0-5.0.pdf
353830 PHS398_CoverPageSupplement_5_0-5.0.pdf
353830 RR_OtherProjectInfo_1_4-1.4.pdf
353830 PerformanceSite_4_0-4.0.pdf
353830 RR_KeyPersonExpanded_4_0-4.0.pdf
353830 PHS398_ResearchPlan_5_0-5.0.pdf
353830 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353830 RR_Budget_3_0-3.0.pdf
353830 RR_SubawardBudget30_3_0-3.0.pdf
353830 PHS398_ModularBudget_1_2-1.2.pdf
353830 PHS_AssignmentRequestForm_3_0-3.0.pdf